Comparative study of Apelin and Glucose levels in COVID-19 patients
Keywords:
adipokine, apelin, COVID-19, diabetes mellitus, glucoseAbstract
A novel coronavirus, known as Severe Acute Respiratory Syndrome- Coronavirus 2, has just emerged as an epidemic danger to worldwide public health, Diabetes increases the severity and mortality rate of COVID-19. Adipokines perform a hormonal function including apelin is the newest finding among adipokines and has drawn much Research interest about its functions. This study aimed to estimate the level of apelin hormone in Covid-19 patients and the relationship of this hormone to the level of glucose. The study included 65 patients and 23 healthy as a control group. Apelin hormone was determined by ELISA technique, the level of the hormone Apelin elevated in male and female Covid-19 patients (3752.8571±81.60529, and 3786.3333±96.92097 respectively pg\ml) when compared to the control group for males and females (112.8462±7.79287, and 151.3000±22.20913 respectively pg\ml), High level of glucose in male and female patients (122.2000±9.703, 145.6667±11.55 mg/dl respectively) when compared to healthy males and females (90.8462±6.346, 102.3000±7.701 mg /dl respectively). This study shows a very high increase of apelin hormone in Covid-19 patients compared to healthy. it can be used as a predictive biomarker for the risk of deterioration and disease progression. also, It has an important role in managing COVID-19 patients.
Downloads
References
Alguwaihes, A. M., Al-Sofiani, M. E., Megdad, M., Albader, S. S., Alsari, M. H., Alelayan, A., and Jammah, A. A. (2020). Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study. Cardiovascular diabetology, 19(1), 1-12.
Alipour, F. G., Ashoori, M. R., Pilehvar-Soltanahmadi, Y., and Zarghami, N. (2017). An overview on biological functions and emerging therapeutic roles of apelin in diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research and Reviews, 11, S919-S923.
Bełtowski, J. (2006). Apelin and visfatin: unique" beneficial" adipokines upregulated in obesity?. Medical science monitor: international medical journal of experimental and clinical research, 12(6), RA112-9.
Bertrand, C., Valet, P., and Castan-Laurell, I. (2015). Apelin and energy metabolism. Front Physiol 6: 115.
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., and Valet, P. (2005). Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology, 146(4), 1764-1771.
Brame, A. L., Maguire, J. J., Yang, P., Dyson, A., Torella, R., Cheriyan, J., and Davenport, A. P. (2015). Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension, 65(4), 834-840.
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., and Cook, D. G. (2018). Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes care, 41(3), 513-521.
Ebrahimzadeh, M., Azizbeigi, K., Salamat, K. M. Z., and Pashaie, S. (2019)The Effect of Aerobic Exercise Training and Curcumin on Aplin Levels, Insulin Resistance and Glucose in Rats with Type 2 Diabetes.
Erener, S. (2020). Diabetes, infection risk and COVID-19. Molecular metabolism, 39, 101044.
Estienne, A., Bongrani, A., Froment, P., and Dupont, J. (2021). Apelin and chemerin receptors are G protein-coupled receptors involved in metabolic as well as reproductive functions: Potential therapeutic implications?. Current Opinion in Endocrine and Metabolic Research, 16, 86-95.
Fairbridge, N. A., Southall, T. M., Ayre, D. C., Komatsu, Y., Raquet, P. I., Brown, R. J., and Christian, S. L. (2015). Loss of CD24 in mice leads to metabolic dysfunctions and a reduction in white adipocyte tissue. PLoS One, 10(11), e0141966.
Fan, X. F., Xue, F., Zhang, Y. Q., Xing, X. P., Liu, H., Mao, S. Z., and Gong, Y. S. (2015). The Apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury. Chest, 147(4), 969-978.
Ferreira, C., Viana, S. D., and Reis, F. (2020). Gut microbiota dysbiosis–immune hyperresponse–inflammation triad in coronavirus disease 2019 (COVID-19): impact of pharmacological and nutraceutical approaches. Microorganisms, 8(10), 1514.
Habchi, M., Duvillard, L., Cottet, V., Brindisi, M. C., Bouillet, B., Beacco, M., and Petit, J. M. (2014). Circulating A pelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control. Clinical endocrinology, 81(5), 696-701.
Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus: A case report. International Journal of Health & Medical Sciences, 5(1), 150-153. https://doi.org/10.21744/ijhms.v5n1.1861
Hu, H., He, L., Li, L., andChen, L. (2016). Apelin/APJ system as a therapeutic target in diabetes and its complications. Molecular genetics and metabolism, 119(1-2), 20-27.
Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma, S., and Fujino, M. (2001). Molecular properties of apelin: tissue distribution and receptor binding. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1538(2-3), 162-171.
Kuba, K., Sato, T., Imai, Y., and Yamaguchi, T. (2019). Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology. Peptides, 111, 62-70.
Lee, M. J., Pramyothin, P., Karastergiou, K., and Fried, S. K. (2014). Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1842(3), 473-481.
Li, M., Fang, H., and Hu, J. (2018). Apelin 13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high fat diet. Molecular Medicine Reports, 18(6), 5784-5790.
Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., and Albaiu, D. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases.
Lv, S., Zhang, X., Feng, Y., Zhou, Y., Cui, B., Yang, Y., & Wang, X. (2020). Intravenous administration of pyroglutamyl apelin-13 alleviates murine inflammatory pain via the kappa opioid receptor. Frontiers in Neuroscience, 14, 929.
Ma, W. Y., Yu, T. Y., Wei, J. N., Hung, C. S., Lin, M. S., Liao, Y. J., and Li, H. Y. (2014). Plasma apelin: a novel biomarker for predicting diabetes. Clinica chimica acta, 435, 18-23.
McGrail, J., Martín-Banderas, L., and Durán-Lobato, M. (2022). Cannabinoids as Emergent Therapy Against COVID-19. Cannabis and Cannabinoid Research.
Mlyczyńska, E., Kurowska, P., Drwal, E., Opydo Chanek, M., Tworzydło, W., Kotula Balak, M., and Rak, A. (2020). Apelin and apelin receptor in human placenta: Expression, signalling pathway and regulation of trophoblast JEG 3 and BeWo cells proliferation and cell cycle. International Journal of Molecular Medicine, 45(3), 691-702.
Mohammadzadeh, G., and Zarghami, N. (2011). Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 16(6), 713.
Mounika, V., Neeli, D. S., Sree, G. S., Mourya, P., and Babu, M. A. (2021, March). Prediction of Type-2 Diabetes using Machine Learning Algorithms. In 2021 International Conference on Artificial Intelligence and Smart Systems (ICAIS) (pp. 127-131). IEEE.
Nadjib, B. M. (2020). Effective antiviral activity of essential oils and their characteristic terpenes against coronaviruses: An update. J. Pharmacol. Clin. Toxicol, 8(1), 1138.
Noori-Zadeh, A., Bakhtiyari, S., Khanjari, S., Haghani, K.,and Darabi, S. (2019). Elevated blood apelin levels in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Research and Clinical Practice, 148, 43-53.
Norouzi, M., Norouzi, S., Ruggiero, A., Khan, M. S., Myers, S., Kavanagh, K., and Vemuri, R. (2021). Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms, 9(6), 1211.
O'Dowd, B. F., Heiber, M., Chan, A., Heng, H. H., Tsui, L. C., Kennedy, J. L., and Nguyen, T. (1993). A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene, 136(1-2), 355-360.
Olszanecka-Glinianowicz, M., Kocełak, P., Nylec, M., Chudek, J., and Zahorska-Markiewicz, B. (2012). Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome. Archives of Medical Science, 8(2), 214-218.
Pal, R., Bhadada, S. K., and Misra, A. (2021). COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 15(2), 505-508.
Phan, L. T., Nguyen, T. V., Luong, Q. C., Nguyen, T. V., Nguyen, H. T., Le, H. Q., and Pham, Q. D. (2020). Importation and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine, 382(9), 872-874.
Roberts, E. M., Newson, M. J., Pope, G. R., Landgraf, R., Lolait, S. J., and O'Carroll, A. M. (2009). Abnormal fluid homeostasis in apelin receptor knockout mice. The Journal of endocrinology, 202(3), 453.
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., and IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice, 157, 107843.
Salles, É. L., Khodadadi, H., Jarrahi, A., Ahluwalia, M., Paffaro Jr, V. A., Costigliola, V., and Baban, B. (2020). Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. Journal of Cellular and Molecular Medicine, 24(21), 12869-12872.
Saravi, S. S. S., and Beer, J. H. (2020). Apelin-potential therapy for COVID-19?. Journal of molecular and cellular cardiology, 145, 84-87.
Sato, T., Suzuki, T., Watanabe, H., Kadowaki, A., Fukamizu, A., Liu, P. P., and Kuba, K. (2013). Apelin is a positive regulator of ACE2 in failing hearts. The Journal of clinical investigation, 123(12), 5203-5211.
Singh, A. K., Gupta, R., Ghosh, A., andMisra, A. (2020). Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 303-310.
Steel, Robert George Douglas, and James Hiram Torrie. 1960. “Principles and Procedures of Statistics.” Principles and Procedures of Statistics.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Wu, Z. H., Tang, Y., and Cheng, Q. (2021). Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta diabetologica, 58(2), 139-144.
Wysocka, M. B., Pietraszek-Gremplewicz, K., and Nowak, D. (2018). The role of apelin in cardiovascular diseases, obesity and cancer. Frontiers in physiology, 9, 557.
Yamauchi, T., Iwabu, M., Okada-Iwabu, M.,and Kadowaki, T. (2014). Adiponectin receptors: a review of their structure, function and how they work. Best practice & research Clinical endocrinology & metabolism, 28(1), 15-23.
Yan, J., Wang, A., Cao, J., and Chen, L. (2020). Apelin/APJ system: an emerging therapeutic target for respiratory diseases. Cellular and Molecular Life Sciences, 77(15), 2919-2930.
Yang, P., Maguire, J. J., and Davenport, A. P. (2015). Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends in pharmacological sciences, 36(9), 560-567.
Zheng, H., Fan, X., Li, X., Zhang, Y., Fan, Y., Zhang, N., and Yang, J. (2016). The association between single nucleotide polymorphisms of the Apelin gene and diabetes mellitus in a Chinese population. Journal of Pediatric Endocrinology and Metabolism, 29(12), 1397-1402.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.